Aptose Biosciences Inc.
APS.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.76M | -5.12M | -7.04M | -5.54M | -1.59M |
| Total Depreciation and Amortization | -290.00K | 111.00K | 102.00K | 99.00K | -275.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 790.00K | 272.00K | 206.00K | 482.00K | -227.00K |
| Change in Net Operating Assets | 1.42M | -2.67M | 792.00K | 2.17M | -5.97M |
| Cash from Operations | -5.84M | -7.41M | -5.94M | -2.80M | -8.06M |
| Capital Expenditure | -- | -- | -- | -- | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 5.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | 8.30M | 7.75M | 2.60M | -- | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | -100.00K | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 829.00K | 6.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 156.00K |
| Cash from Financing | 8.30M | 7.75M | 2.50M | 829.00K | 6.81M |
| Foreign Exchange rate Adjustments | -- | -- | -2.00K | 2.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.46M | 339.00K | -3.45M | -1.96M | -1.26M |